U.S. Panel Says Seniors Should Get Pfizer’s Prevnar 13

August 14, 2014 4:39 AM

22 0

Pfizer Inc. (PFE:US) won the backing of a key U.S. advisory panel to recommend its vaccine Prevnar 13 for people ages 65 and older to help prevent infections including pneumonia and meningitis.

The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices, or ACIP, voted 13-2 yesterday to add Prevnar 13 to a list of recommended vaccines that includes Merck & Co.’s Pneumovax 23. The committee plans to revisit the recommendation in 2018.

Read more

To category page